Bill 119 s 526, also known as the "Pharmacy Benefit Manager Transparency Act," aims to address issues related to pharmacy benefit management services for prescription drugs. The bill seeks to prevent unfair and deceptive acts or practices, as well as the dissemination of false information in this industry. The main goal of the bill is to increase transparency and accountability within the pharmacy benefit management sector. This includes requiring pharmacy benefit managers to disclose information about their pricing practices, rebates, and any potential conflicts of interest. By doing so, the bill aims to ensure that consumers have access to accurate and reliable information when it comes to their prescription drug coverage. Additionally, the bill includes provisions to protect consumers from being misled or deceived by pharmacy benefit managers. This includes prohibiting practices that could result in higher costs for consumers or limit their access to necessary medications. Overall, Bill 119 s 526 seeks to promote fairness and honesty within the pharmacy benefit management industry, ultimately benefiting consumers and ensuring that they receive the best possible care when it comes to their prescription drug coverage.
Bill 119 s 526, also known as the "Pharmacy Benefit Manager Transparency Act," aims to address issues related to pharmacy benefit management services for prescription drugs. The bill seeks to prevent unfair and deceptive acts...